Skip to main content

Corcept Therapeutics Inc

CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001088856

In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Corcept Therapeutics Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CORT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders210199−11
Shares81.6M80.5M−1.12M (−1.4%)
Value$1.94B$1.77B−$171.8M (−8.9%)

New holders (16)

Institutions that held Corcept Therapeutics Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CORT in Q2 2021
InstitutionSharesValue% of portfolio
Jefferies Group LLC48,300$1.06M0.02%
Cowen and Company, LLC38,834$854.0K0.05%
Ergoteles LLC28,309$623.0K0.01%
Walleye Capital LLC23,514$517.0K0.02%
Jane Street Group, LLC21,744$478.0K0.00%
Oppenheimer & Co Inc20,000$440.0K0.01%
Stifel Financial Corp10,273$226.0K0.00%
Dark Forest Capital Management LP10,064$221.0K0.10%
Camden Capital, LLC9,293$204.0K0.05%
Group One Trading, L.P.2,764$61.0K0.00%
Walleye Trading LLC2,523$56.0K0.00%
Leonteq Securities AG1,100$24.2K0.00%
Quantbot Technologies LP666$14.0K0.00%
Lake Point Wealth Management430$9.00K0.00%
Advisory Services Network, LLC200$4.00K0.00%
IFP Advisors, Inc156$4.00K0.00%

Sold out (27)

Institutions that held Corcept Therapeutics Inc at the end of Q1 2021 and filed for Q2 2021 without it.